SG10201609137PA - Gamma-polyglutamic acid and zinc compositions - Google Patents

Gamma-polyglutamic acid and zinc compositions

Info

Publication number
SG10201609137PA
SG10201609137PA SG10201609137PA SG10201609137PA SG10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA SG 10201609137P A SG10201609137P A SG 10201609137PA
Authority
SG
Singapore
Prior art keywords
polyglutamic acid
gamma
compositions
zinc
zinc compositions
Prior art date
Application number
SG10201609137PA
Inventor
Fred Chung Jinhyuk
Original Assignee
Xylonix Ip Holdings Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xylonix Ip Holdings Pte Ltd filed Critical Xylonix Ip Holdings Pte Ltd
Priority to SG10201609137PA priority Critical patent/SG10201609137PA/en
Priority to SG11201903732TA priority patent/SG11201903732TA/en
Priority to EP17809399.3A priority patent/EP3534915B1/en
Priority to DK17809399.3T priority patent/DK3534915T3/en
Priority to PCT/SG2017/050544 priority patent/WO2018084805A1/en
Priority to KR1020197015742A priority patent/KR20190122203A/en
Priority to AU2017354786A priority patent/AU2017354786B2/en
Priority to CA3042234A priority patent/CA3042234A1/en
Priority to US16/346,283 priority patent/US20190247428A1/en
Priority to JP2019545868A priority patent/JP2019534046A/en
Priority to MX2019005103A priority patent/MX2019005103A/en
Priority to CN201711096131.4A priority patent/CN108014130A/en
Publication of SG10201609137PA publication Critical patent/SG10201609137PA/en
Priority to MX2022013541A priority patent/MX2022013541A/en
Priority to JP2022144662A priority patent/JP2023016043A/en
Priority to AU2023203216A priority patent/AU2023203216A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2045—Polyamides; Polyaminoacids, e.g. polylysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Abstract

GAMMA-POLYGLUTAMIC ACID AND ZINC COMPOSITIONS The invention relates to nutritional supplement compositions comprising g -polyglutamic acid, a zinc salt, and a gastro-resistant material for use as a dietary supplement to provide zinc to persons desiring or in need thereof, and methods for preparing such compositions as solid dosage forms such as tablets and capsules, and as liquid dosage forms. No suitable figure.
SG10201609137PA 2016-11-01 2016-11-01 Gamma-polyglutamic acid and zinc compositions SG10201609137PA (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SG10201609137PA SG10201609137PA (en) 2016-11-01 2016-11-01 Gamma-polyglutamic acid and zinc compositions
CA3042234A CA3042234A1 (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions
US16/346,283 US20190247428A1 (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions
DK17809399.3T DK3534915T3 (en) 2016-11-01 2017-10-31 GAMMA-POLYGLUTAMINIC ACID AND ZINC COMPOUNDS
PCT/SG2017/050544 WO2018084805A1 (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions
KR1020197015742A KR20190122203A (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc composition
AU2017354786A AU2017354786B2 (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions
SG11201903732TA SG11201903732TA (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions
EP17809399.3A EP3534915B1 (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions
JP2019545868A JP2019534046A (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc composition
MX2019005103A MX2019005103A (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions.
CN201711096131.4A CN108014130A (en) 2016-11-01 2017-11-01 The composition of gamma-polyglutamic acid and zinc
MX2022013541A MX2022013541A (en) 2016-11-01 2019-04-30 Gamma-polyglutamic acid and zinc compositions.
JP2022144662A JP2023016043A (en) 2016-11-01 2022-09-12 Gamma-polyglutamic acid and zinc compositions
AU2023203216A AU2023203216A1 (en) 2016-11-01 2023-05-23 Gamma-polyglutamic acid and zinc compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SG10201609137PA SG10201609137PA (en) 2016-11-01 2016-11-01 Gamma-polyglutamic acid and zinc compositions

Publications (1)

Publication Number Publication Date
SG10201609137PA true SG10201609137PA (en) 2018-06-28

Family

ID=60582642

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201609137PA SG10201609137PA (en) 2016-11-01 2016-11-01 Gamma-polyglutamic acid and zinc compositions
SG11201903732TA SG11201903732TA (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201903732TA SG11201903732TA (en) 2016-11-01 2017-10-31 Gamma-polyglutamic acid and zinc compositions

Country Status (11)

Country Link
US (1) US20190247428A1 (en)
EP (1) EP3534915B1 (en)
JP (2) JP2019534046A (en)
KR (1) KR20190122203A (en)
CN (1) CN108014130A (en)
AU (2) AU2017354786B2 (en)
CA (1) CA3042234A1 (en)
DK (1) DK3534915T3 (en)
MX (2) MX2019005103A (en)
SG (2) SG10201609137PA (en)
WO (1) WO2018084805A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102094182B1 (en) * 2018-06-28 2020-03-30 주식회사 알랙스탠드 water-soluble polyglutamic acid complex composition containing zinc
CN117224690B (en) * 2023-11-10 2024-01-30 江苏海王健康生物科技有限公司 Gamma-polyglutamic acid mixture, composition and preparation method as auxiliary agent

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2712583B2 (en) * 1989-06-28 1998-02-16 味の素株式会社 Foods and drinks containing easily absorbable minerals
JP3232718B2 (en) * 1992-03-24 2001-11-26 味の素株式会社 Easy-absorbable mineral-containing composition and food and drink containing it
JP3551149B2 (en) * 1992-03-24 2004-08-04 味の素株式会社 Easy-absorbable mineral-containing composition and food and drink containing it
US5447732A (en) * 1992-11-25 1995-09-05 Ajinomoto Co., Inc. High-absorption mineral-containing composition and foods
ITMI950515A0 (en) * 1995-03-16 1995-03-16 Valpharma Sa GASTRO-RESISTANT FORMULATIONS CONTAINING ZINC
JPH11313618A (en) * 1998-05-06 1999-11-16 Yoshio Inoue Mineral (zinc) formulation for livestock gentle to stomach and its production
WO2004080210A1 (en) * 2003-03-14 2004-09-23 Boehringer Ingelheim Danmark A/S Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea
JP4457641B2 (en) * 2003-11-10 2010-04-28 味の素株式会社 Gelatin capsule
JP5162812B2 (en) * 2004-07-08 2013-03-13 大正製薬株式会社 Zinc-containing composition for oral administration
JPWO2007043606A1 (en) * 2005-10-12 2009-04-16 株式会社ジェノラックＢｌ Antidiabetic drug comprising an anionic polyamino acid / metal complex
AU2009344184B2 (en) * 2009-04-10 2016-05-12 Cypress Pharmaceuticals, Inc. Phosphate-binding magnesium salts and uses thereof
JO3635B1 (en) * 2009-05-18 2020-08-27 Millennium Pharm Inc Solid pharmaceutical compositions and processes for their production
CN101692851B (en) * 2009-10-20 2014-01-08 华中农业大学 Application of r-polyglutamic acid or salt thereof in dairy product as addition agent
CN101716180B (en) * 2009-11-06 2013-04-24 广西强寿药业集团有限公司 Combined medicament for supplementing zinc and calcium and preparation method thereof
CA2800235C (en) * 2010-03-10 2018-10-16 Lupin Limited Rifaximin ready-to-use suspension
CN103917231B (en) * 2011-09-13 2016-09-28 药品循环有限责任公司 Combination formulations of histone deacetylase inhibitor and bendamustine and application thereof
BR112015011699B1 (en) * 2012-11-21 2021-01-12 KBS Research, LLC herbal supplements and their uses
TWI660748B (en) * 2013-03-01 2019-06-01 日商大塚製藥股份有限公司 Suspension for oral administration comprising amorphous tolvaptan
CN103690521B (en) * 2013-11-29 2016-07-06 湖北福人金身药业有限公司 A kind of Zinc calcium gluconate oral solution
JP2016069303A (en) * 2014-09-29 2016-05-09 タカラバイオ株式会社 Hair loss inhibiting composition containing fucoidan as active ingredient
ES2630106T3 (en) * 2014-10-07 2017-08-18 Cyprumed Gmbh Pharmaceutical formulations for oral administration of peptide or protein drugs
US10105322B2 (en) * 2014-10-08 2018-10-23 Synthetic Biologics, Inc. Beta-lactamase formulations and uses thereof
JP6716464B2 (en) * 2014-12-03 2020-07-01 ノーベルファーマ株式会社 Zinc acetate hydrate tablet and method for producing the same

Also Published As

Publication number Publication date
MX2019005103A (en) 2019-10-30
JP2019534046A (en) 2019-11-28
DK3534915T3 (en) 2024-01-22
CA3042234A1 (en) 2018-05-11
KR20190122203A (en) 2019-10-29
CN108014130A (en) 2018-05-11
EP3534915B1 (en) 2023-12-20
MX2022013541A (en) 2022-11-16
JP2023016043A (en) 2023-02-01
WO2018084805A1 (en) 2018-05-11
AU2017354786A1 (en) 2019-05-16
SG11201903732TA (en) 2019-05-30
EP3534915A1 (en) 2019-09-11
AU2023203216A1 (en) 2023-06-22
AU2017354786B2 (en) 2023-02-23
US20190247428A1 (en) 2019-08-15

Similar Documents

Publication Publication Date Title
PH12017500802B1 (en) Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
ZA201405101B (en) "new indolizine compounds, a process for their preparation and pharmaceutical compositions containing them."
WO2015165413A8 (en) New stable antibody-drug conjugate, preparation method therefor, and use thereof
PH12016502463A1 (en) Bi-layer dual release probiotic tablets
WO2014180889A8 (en) Methods and compositions for the treatment of cancer
EP3067059A4 (en) Pharmaceutical composition for preventing or treating thyroid diseases, containing lonicera caerulea l. var. edulis fruit extract as active ingredient
MX2016016995A (en) Composition containing phytic acid, magnesium and polyphenols for the treatment or prevention of renal lithiasis.
IL272806A (en) Boronic acid derivatives, their preparation and pharmaceutical compositions containing them
IL280376A (en) Boronic acid derivatives, their preparation and pharmaceutical compositions containing them
IL228265A (en) Pyrido{b-3.2}pyrazine derivatives, their preparation and pharmaceutical compositions containing them
MX2014012164A (en) Compositions containing probiotics and a bee pollen/clay complex, preparation method thereof and uses of same in nutrition and therapeutics.
PT3102187T (en) Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
MX2022013541A (en) Gamma-polyglutamic acid and zinc compositions.
WO2016080796A3 (en) Pharmaceutical composition, containing sesquiterpene compound, for preventing or treating stat3-mediated diseases, and use thereof
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MD4615B1 (en) Isolated solid form of anamorelin monohydrochloride, pharmaceutical composition and method of making a pharmaceutical dosage form comprising it
HK1214600A1 (en) Phosphorus-containing pyrido[2,3-d]pyrimidin-7-ones or their pharmaceutically acceptable salts, pharmaceutical compositions containing this compound and use thereof [23-d]-7-
WO2015022560A8 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
SG10201909401UA (en) Oral delivery product
WO2014049566A3 (en) Nutritional kit
UA92914U (en) Antioxidant and immunomodulating drugs "selcivit"
GR1008442B (en) Pharmaceutical formulation containing aripiprazole or salt thereof
EP2796130A3 (en) Immediate release tablets of rasagiline hemitartrate
RU2011132300A (en) METHOD FOR PREVENTING PREMATURE AGING OF A HUMAN BODY
PL3344281T3 (en) Pharmaceutical composition containing at least one digestive enzyme for use in artificial nutrition